A 20-hospital, 3-year ICMR study of over 150,000 patients finds that carbapenem drug-resistant infections are driving up both deaths and treatment costs
A large multi-centre study of over 150,000 patients in India's 20 tertiary-care hospitals has put a stark number on one of the top

























































































































































































